The Current Ratio as of August 2024 (TTM) for Deciphera Pharmaceuticals, Inc. (DCPH) is 4.19

According to Deciphera Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.19. This represents a change of -4.07% compared to the average of 4.37 of the last 4 quarters.

Deciphera Pharmaceuticals, Inc. (DCPH) Historical Current Ratio (quarterly & annually)

How has DCPH Current Ratio performed in the past?

The mean historical Current Ratio of Deciphera Pharmaceuticals, Inc. over the last ten years is 8.78. The current 4.19 Current Ratio has changed 4.68% with respect to the historical average. Over the past ten years (40 quarters), DCPH's Current Ratio was at its highest in in the September 2018 quarter at 18.45. The Current Ratio was at its lowest in in the September 2016 quarter at 0.

Deciphera Pharmaceuticals, Inc. (DCPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Deciphera Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Deciphera Pharmaceuticals, Inc. (DCPH) Average Current Ratio

How has DCPH Current Ratio performed in the past?

The current Current Ratio of Deciphera Pharmaceuticals, Inc. (DCPH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Deciphera Pharmaceuticals, Inc. (DCPH) Current Ratio vs. Peers

How is DCPH’s Current Ratio compared to its peers?

Deciphera Pharmaceuticals, Inc.’s Current Ratio is greater than Eagle Pharmaceuticals, Inc. (2.16), greater than ANI Pharmaceuticals, Inc. (3.97), greater than Phibro Animal Health Corporation (2.94), greater than Prestige Consumer Healthcare Inc. (3.23), greater than Evotec SE (1.83), greater than Supernus Pharmaceuticals, Inc. (1.91), greater than Collegium Pharmaceutical, Inc. (1.11), greater than Neurocrine Biosciences, Inc. (4.19), greater than Ironwood Pharmaceuticals, Inc. (3.92), greater than Alkermes plc (2.99), greater than Avadel Pharmaceuticals plc (2.82), greater than Amphastar Pharmaceuticals, Inc. (3.52), greater than Procaps Group S.A. (1.47), less than Silver Spike Investment Corp. (6.09),

Build a custom stock screener for Deciphera Pharmaceuticals, Inc. (DCPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Deciphera Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Deciphera Pharmaceuticals, Inc. (DCPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Deciphera Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.